Recursion Pharmaceuticals Inc (NASDAQ: RXRX) Has Another Chance To Impress You
Currently, there are 389.55M common shares owned by the public and among those 305.89M shares have been available to trade. The company’s stock has a 5-day price change of 35.85% and -16.28% over the past three months. RXRX shares are trading -14.79% year to date (YTD), with the 12-month market performance down to -32.87% lower. […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Stock That Needs Special Handling
Currently, there are 389.55M common shares owned by the public and among those 305.89M shares have been available to trade. The company’s stock has a 5-day price change of -20.60% and -46.15% over the past three months. RXRX shares are trading -37.87% year to date (YTD), with the 12-month market performance down to -51.89% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 389.55M common shares owned by the public and among those 305.72M shares have been available to trade. The company’s stock has a 5-day price change of -13.02% and -19.75% over the past three months. RXRX shares are trading -14.05% year to date (YTD), with the 12-month market performance down to -43.70% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 389.55M common shares owned by the public and among those 305.72M shares have been available to trade. The company’s stock has a 5-day price change of -0.73% and 9.25% over the past three months. RXRX shares are trading 0.44% year to date (YTD), with the 12-month market performance down to -38.66% lower. […]
Look At Analyst Expectations For A Better Read On Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 389.55M common shares owned by the public and among those 305.79M shares have been available to trade. The company’s stock has a 5-day price change of -3.64% and -14.88% over the past three months. RXRX shares are trading -6.07% year to date (YTD), with the 12-month market performance down to -39.75% lower. […]
Reviewing The Case For Recursion Pharmaceuticals Inc (RXRX) Going Higher
Currently, there are 389.55M common shares owned by the public and among those 305.79M shares have been available to trade. The company’s stock has a 5-day price change of -12.25% and -7.05% over the past three months. RXRX shares are trading -2.51% year to date (YTD), with the 12-month market performance down to -44.67% lower. […]
Recursion Pharmaceuticals Inc (RXRX) Testing Investors’ Patience Right Now
Currently, there are 183.21M common shares owned by the public and among those 146.52M shares have been available to trade. Insiders at the company have transacted a total of 136 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 56 of these insider trades were purchases, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX) – Suitable For Long Term Buy?
Currently, there are 183.21M common shares owned by the public and among those 151.91M shares have been available to trade. Insiders at the company have transacted a total of 143 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 61 of these insider trades were purchases, […]
Now Is A Suitable Moment For A Long-Term Purchase Of Recursion Pharmaceuticals Inc (NASDAQ: RXRX)
Currently, there are 183.21M common shares owned by the public and among those 151.89M shares have been available to trade. Insiders at the company have transacted a total of 153 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 65 of these insider trades were purchases, […]
Recursion Pharmaceuticals Inc (NASDAQ: RXRX): Reassessing Prospects
Recursion Pharmaceuticals Inc (RXRX) concluded trading on Thursday at a closing price of $9.90, with 4.24 million shares of worth about $41.99 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.75% during that period and on Thursday the price saw a gain of […]
